Genemod

About Genemod

Genemod provides cloud-based LIMS (Laboratory Information Management System) and ELN (Electronic Lab Notebook) software to simplify lab management and drive scientific research, with customizable features tailored for Biotech R&D.

Products & Services

Inventory Management:Includes virtual freezers, consumables tracking, orders management, and alerts for low stock and expirations, with GxP-ready compliance.

Notebook (ELN):Features experiments, protocols, version control for full traceability, and reports with searchable and exportable entries.

Platform:Offers Genemod AI, security features, integrations with other systems, and equipment management.

Specialties

Laboratory Management Software LIMS (Laboratory Information Management System) ELN (Electronic Lab Notebook) Biotech R&D Inventory Management Protocol and Data Capture

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 4500000 MR: - FA: $4.5 million FAN: 4500000	D: 2023-05-04 FD: 2023-05-04	4 investors

Seed Latest

2023-05-04

$4.5M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Stacy S

Scientist

L

Lydia M.

Enterprise Pharma

A

Anton N.

Mid-Market R&D

S

Sophia S.

N

Neil G.

Mid-Market R&D

J

Jiah L.

Preclinical Biotech

View 4 more team members with Pro

Unlock Full Team Directory

Recent News

Genemod Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised